Literature DB >> 20048001

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).

Bin Zhao1, Li Li, Karen Tumaneng, Cun-Yu Wang, Kun-Liang Guan.   

Abstract

The Yes-associated protein (YAP) transcription coactivator is a key regulator of organ size and a candidate human oncogene. YAP is inhibited by the Hippo pathway kinase cascade, at least in part via phosphorylation of Ser 127, which results in YAP 14-3-3 binding and cytoplasmic retention. Here we report that YAP is phosphorylated by Lats on all of the five consensus HXRXXS motifs. Phosphorylation of Ser 381 in one of them primes YAP for subsequent phosphorylation by CK1delta/epsilon in a phosphodegron. The phosphorylated phosphodegron then recruits the SCF(beta-TRCP) E3 ubiquitin ligase, which catalyzes YAP ubiquitination, ultimately leading to YAP degradation. The phosphodegron-mediated degradation and the Ser 127 phosphorylation-dependent translocation coordinately suppress YAP oncogenic activity. Our study identified CK1delta/epsilon as new regulators of YAP and uncovered an intricate mechanism of YAP regulation by the Hippo pathway via both S127 phosphorylation-mediated spatial regulation (nuclear-cytoplasmic shuttling) and the phosphodegron-mediated temporal regulation (degradation).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048001      PMCID: PMC2802193          DOI: 10.1101/gad.1843810

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  48 in total

Review 1.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

3.  Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.

Authors:  Bin Zhao; Joungmok Kim; Xin Ye; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

4.  Expression of Yes-associated protein in common solid tumors.

Authors:  Angela A Steinhardt; Mariana F Gayyed; Alison P Klein; Jixin Dong; Anirban Maitra; Duojia Pan; Elizabeth A Montgomery; Robert A Anders
Journal:  Hum Pathol       Date:  2008-08-13       Impact factor: 3.466

5.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

6.  PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.

Authors:  Eleonora Lapi; Silvia Di Agostino; Sara Donzelli; Hilah Gal; Eytan Domany; Gideon Rechavi; Pier Paolo Pandolfi; David Givol; Sabrina Strano; Xin Lu; Giovanni Blandino
Journal:  Mol Cell       Date:  2008-12-26       Impact factor: 17.970

7.  Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).

Authors:  Tsutomu Oka; Virginia Mazack; Marius Sudol
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

8.  Phosphorylation of the tumor suppressor fat is regulated by its ligand Dachsous and the kinase discs overgrown.

Authors:  Richelle Sopko; Elizabeth Silva; Lesley Clayton; Laura Gardano; Miriam Barrios-Rodiles; Jeff Wrana; Xaralabos Varelas; Natalia I Arbouzova; Sanjeev Shaw; Sakura Saburi; Hitoshi Matakatsu; Seth Blair; Helen McNeill
Journal:  Curr Biol       Date:  2009-06-18       Impact factor: 10.834

9.  In vivo analysis of Yorkie phosphorylation sites.

Authors:  H Oh; K D Irvine
Journal:  Oncogene       Date:  2009-03-30       Impact factor: 9.867

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more
  580 in total

1.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

3.  Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

Authors:  Weiquan Li; Lizhong Wang; Hiroto Katoh; Runhua Liu; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

Review 4.  The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation.

Authors:  Huan Liu; Dandan Jiang; Fangtao Chi; Bin Zhao
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

5.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

6.  Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation.

Authors:  Kun Zhang; Eva Rodriguez-Aznar; Norikazu Yabuta; Robert J Owen; Jose M Mingot; Hiroshi Nojima; M Angela Nieto; Gregory D Longmore
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

7.  The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

Authors:  Chen-Ying Liu; Zheng-Yu Zha; Xin Zhou; Heng Zhang; Wei Huang; Di Zhao; Tingting Li; Siew Wee Chan; Chun Jye Lim; Wanjin Hong; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

8.  Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.

Authors:  Yasmine Touil; Wassila Igoudjil; Matthieu Corvaisier; Anne-Frédérique Dessein; Jérôme Vandomme; Didier Monté; Laurence Stechly; Nicolas Skrypek; Carole Langlois; Georges Grard; Guillaume Millet; Emmanuelle Leteurtre; Patrick Dumont; Stéphanie Truant; François-René Pruvot; Mohamed Hebbar; Fan Fan; Lee M Ellis; Pierre Formstecher; Isabelle Van Seuningen; Christian Gespach; Renata Polakowska; Guillemette Huet
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

9.  Targeting YAP Degradation by a Novel 1,2,4-Oxadiazole Derivative via Restoration of the Function of the Hippo Pathway.

Authors:  Eman M E Dokla; Chun-Sheng Fang; Po-Chen Chu; Chih-Shiang Chang; Khaled A M Abouzid; Ching S Chen
Journal:  ACS Med Chem Lett       Date:  2020-03-05       Impact factor: 4.345

10.  Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase.

Authors:  Paulo Ribeiro; Maxine Holder; David Frith; Ambrosius P Snijders; Nicolas Tapon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.